CAR T-cell therapy tricks cancer cells with decoy, increases treatment efficiency in B-cell acute lymphoblastic leukemia
B-cell acute lymphoblastic leukemia (B-ALL) is a life-threatening and highly aggressive form of blood cancer. It is the most ...
MyChesCo on MSN1mon
Cabaletta Bio to Present Pioneering Clinical Data on Rese-cel at Major Scientific Conferences
PHILADELPHIA, PA — Cabaletta Bio, Inc. (Nasdaq: CABA) announced plans to showcase updated clinical data on its investigational CD19-CAR T ... Conference on Lymphocyte Engineering in Munich ...
Medical Xpress8d
Acute Lymphoblastic Leukemia
Patients with relapsed or refractory CD19-positive B-cell acute lymphoblastic ... which if they were normal would be referred to as lymphocytes but are seen in this disease in a relatively ...
Nature8y
Fully human CD19-specific chimeric antigen receptors for T-cell therapy
Impressive results have been achieved by adoptively transferring T-cells expressing CD19-specific CARs with binding domains from murine mAbs to treat B-cell malignancies. T-cell mediated immune ...